Literature DB >> 17151809

Surgery for obscure lower gastrointestinal bleeding in India.

Dinesh Singhal1, Neerav Goyal, Subash Gupta, S Nundy.   

Abstract

Western patients with obscure lower gastrointestinal hemorrhage (OLGIH) are usually 60 years or older, bleed from colonic diverticulosis or angiodysplasia, and need localizing investigations. In India, patients are younger, the causes of bleeding different, and health resources scarce. We followed a policy of early surgical exploration operation and excision of the bleeding source or, if this was not identified, did a right hemicolectomy. The outcome of this strategy was evaluated. Between 1996 and 2003, we managed 62 patients with OLGIH. Localizing investigations such as enteroclysis, radioisotope scanning, angiography, and peroperative enteroscopy were infrequently performed. Fifty patients underwent surgery, emergency (35 pts) or elective (15 pts), and comprised the study group. At operation the lesion was localized in 33 (66%) patients (jejunum in 9 and terminal ileum or cecum in 24) and was resected. In 17 patients no lesion was found and they had a right hemicolectomy. The 30-day mortality was six patients (12%) and included persistent bleeding (three), liver failure (one), and chest infection (one). Five (10%) patients rebled after operation at a mean follow-up of 31 months. Cirrhosis (P=0.003) as a comorbid illness was the only significant factor for rebleed in the right hemicolectomy group. Advanced age (>60 years; P=0.08) might be another risk factor in a larger study. In conclusion, patients with obscure OLGIH in India should have an early operation. If a lesion is not detected, a right hemicolectomy may be done. In this group those with cirrhosis have a higher chance of rebleed, as well as, perhaps, elderly patients.

Entities:  

Mesh:

Year:  2006        PMID: 17151809     DOI: 10.1007/s10620-006-9190-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  16 in total

1.  Obscure lower gastrointestinal tract bleeding.

Authors:  M G Thomas
Journal:  Br J Surg       Date:  1999-05       Impact factor: 6.939

2.  The private health sector in India.

Authors:  Amit Sengupta; Samiran Nundy
Journal:  BMJ       Date:  2005-11-19

Review 3.  Occult gastrointestinal bleeding. General overview and approach.

Authors:  V R Mujica; J S Barkin
Journal:  Gastrointest Endosc Clin N Am       Date:  1996-10

4.  Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study.

Authors:  Giovanni D De Palma; Maria Rega; Stefania Masone; Francesco Persico; Saverio Siciliano; Francesco Patrone; Luigi Matantuono; Giovanni Persico
Journal:  Gastrointest Endosc       Date:  2005-10       Impact factor: 9.427

Review 5.  Surgical management of gastrointestinal bleeding.

Authors:  B E Stabile; M J Stamos
Journal:  Gastroenterol Clin North Am       Date:  2000-03       Impact factor: 3.806

6.  Portal hypertensive jejunopathy: a case control study.

Authors:  Nutan Desai; Devendra Desai; Vijayashree Pethe; K P Deodhar; Prabha Sawant; Sucharita Nanivadekar
Journal:  Indian J Gastroenterol       Date:  2004 May-Jun

7.  The diagnostic yield of superior mesenteric angiography: correlation with the pattern of gastrointestinal bleeding.

Authors:  J J Fiorito; L J Brandt; O Kozicky; I M Grosman; S Sprayragen
Journal:  Am J Gastroenterol       Date:  1989-08       Impact factor: 10.864

8.  Use of technetium-labeled red blood cell scintigraphy in the detection and management of gastrointestinal hemorrhage.

Authors:  G R Voeller; G Bunch; L G Britt
Journal:  Surgery       Date:  1991-10       Impact factor: 3.982

9.  Value of laparotomy in the diagnosis of obscure gastrointestinal haemorrhage.

Authors:  M P Lewis; D E Khoo; J Spencer
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

10.  Efficacy of intraoperative enteroscopy in diagnosis and prevention of recurrent, occult gastrointestinal bleeding.

Authors:  A M Ress; J C Benacci; M G Sarr
Journal:  Am J Surg       Date:  1992-01       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.